Ryan Spencer is CEO and Director of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 260,733 shares of DVAX, which is worth approximately $3.6 Million. The most recent transaction as insider was on Aug 14, 2020, when has been sold 1,518 shares (Common Stock) at a price of $3.39 per share, resulting in proceeds of $5,146. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 261K
29.7% 3M change
29.7% 12M change
Total Value Held $3.6 Million

Ryan Spencer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2020
BUY
Grant, award, or other acquisition
$5,146 $3.39 p/Share
1,518 Added 2.55%
58,059 Common Stock

Also insider at

CDTX
Cidara Therapeutics, Inc. Healthcare
RS

Ryan Spencer

CEO and Director
Emeryville, CA

Track Institutional and Insider Activities on DVAX

Follow DYNAVAX TECHNOLOGIES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVAX shares.

Notify only if

Insider Trading

Get notified when an Dynavax Technologies Corp insider buys or sells DVAX shares.

Notify only if

News

Receive news related to DYNAVAX TECHNOLOGIES CORP

Track Activities on DVAX